volitionrx.com Report : Visit Site

Technical data of the volitionrx.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host volitionrx.com. Currently, hosted in United States and its service provider is CIDCO Incorporated .

the related websites

proactiveinvestors.co.uk hl.co.uk bloomberg.com bbc.co.uk bvm.gov.za southerncountiespetanque.org.uk savageclub.com personalitypage.com lse.ac.uk allesleyparkmedicalcentre.co.uk 50states.com legislation.gov.uk kingstandunipractice.co.uk 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called nginx containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

volition menu home nu.q ™ press room contact us investors brighter tomorrow the dedicated team at volition have a shared goal – to save lives by revolutionizing the way disease, and especially cancer, is diagnosed throughout the world. watch company video watch a video of volition's lab in belgium early diagnosis is key as cancer screening programs become more and more widespread, our products can help to diagnose a range of cancers quickly , simply , accurately and cost effectively . early diagnosis has the potential to not only prolong the life of patients, but also to improve their quality of life. find out more “early detection of cancer greatly increases the chances for successful treatment” world health organization current cancer diagnosis frequently involves expensive, unpleasant and, often, invasive testing. using our nu.q ™ technology we aim to make cancer diagnosis as accessible as cholesterol or pregnancy testing dr. jake micallef, phd, mba cso for more information on nu.q ™ click here a simple test, with a small amount of blood rethinking the approach to cancer nu.q ™ represents a powerful step change in rethinking the approach to cancer. it is a simple solution to the challenging problem of early cancer diagnosis . our expert team volition was established in 2010 when our team saw a chance to bring together the long-established elisa diagnostic technology with the cutting-edge nucleosome detection and analysis techniques. we have grown over the years and are now a collective force of distinct individuals but our aim is the same – to save lives by revolutionizing the way cancer is diagnosed. cameron reynolds mba president & chief executive officer cameron is an experienced entrepreneurial executive, with expertise in biotechnology companies. he has extensive experience in the management, structuring, and strategic planning of start-up companies and has held positions including chief executive officer, chief financial officer, and non-executive director of public and private enterprises. cameron was educated at the university of western australia receiving both a bachelor of commerce and an mba. read more david vanston mba, fcca group chief financial officer david has 20 years of financial management experience. prior to volition and octo telematics, david held positions as vice president of excorp medical, inc., an early-stage company, chief financial officer for growhow ltd and vice president europe, finance for monster worldwide, inc. david managed and oversaw the accounting, finance, tax, treasury, financial planning and analysis of the business. david is a certified chartered accountant and holds an mba from warwick business school. read more jake micallef phd mba chief scientific officer jake is an experienced scientist with expertise in research and development and in the management of early stage biotechnical companies, including the manufacturing of biotechnology products and the establishment of manufacturing operations. jake received his bsc in biology and chemistry, and his phd in physical chemistry from king’s college london. in addition, he received his msc in chemical pathology from st thomas’ hospital medical school, and his mba from imperial college management school. read more louise day chief marketing and communications officer louise brings more than 20 years of marketing, sales and leadership experience to her role at volition. since 2011, she has served as director and owner of aculd ltd, a strategic marketing consultancy specializing in healthcare. formerly louise worked in various roles at reckitt benckiser including some overseas posts in paris and new york. she holds a bachelor of arts in business studies from sheffield hallam university. read more jason terrell md chief medical officer & chief executive officer of volition america, inc. jason has expertise in clinical medicine and in laboratory diagnostics. he was educated at hardin-simmon university (biochemistry) where he graduated summa cum laude, also receiving the holland medal of honor. he received his doctor of medicine from the university of texas medical school at houston and affiliate md anderson cancer center. jason has a strong grounding in both medicine and more specifically in diagnostics and product commercialization. read more gaetan michel phd chief executive officer of belgian volition sprl gaetan has over 10 years of experience in production management. following the completion of his phd in 2002, gaetan joined aat (advanced array technology), a university of namur spin-off company as project manager in proteomics. aat later became eat (eppendorf array technology), part of the german eppendorf biotech company, where gaetan became production manager and was involved in establishing production processes and equipment. from 2007 to 2010 he worked for kitozyme, a global manufacturer of biopolymers of fungal origin with its core business in weight management, digestive and cardiovascular health. read more jasmine kway ph.d chief executive officer, singapore volition jasmine has a proven track record in achieving positive business results by developing strategic business alliances, identifying new markets, and developing business processes. as a thought leader in technology management and commercialization, she has worked with numerous health and regulatory bodies across asia and has successfully commercialised technologies and expanded companies into the asian markets. jasmine has a bachelor of engineering and a doctor of philosophy in oceanography from the national university of singapore. read more mark eccleston phd, mba business development director dr mark eccleston is an enthusiastic and passionate biotechnology entrepreneur with over 20 years experience in the sector. he holds a phd in polymer chemistry for biomedical applications and gained an mba (entrepreneurship) from the university of dundee in 2008. mark is the managing director of oncolytika ltd. a technical consultancy company working with international private and public limited companies operating in the diagnostics and therapeutic sectors as well as academia. dr eccleston is the business development director at volition, a company developing next generation blood tests for early detection of cancer. volition’s epigenetics based immunoassay approach to rapid, affordable cancer diagnostics is intended to revolutionise cancer screening and diagnosis. mark coordinates the commercialisation of volition’s research use kit range based on this proprietary nucleosomics® technology platform. read more rod rootsaert llb corporate secretary rod is an experienced legal and corporate secretary with over ten years’ experience in providing corporate, legal and administrative services to start-up companies. he previously served as corporate secretary for several junior mining companies in the united kingdom. rod received a bachelor of laws degree from the university of western australia. read more scott powell phd executive vice president, investor relations & chief financial officer of volition america, inc. scott has nearly 20 years of experience in the u.s. capital markets and investor relations. scott has served as head of investor relations for four public companies, including volition, and worked for several years as an investment banker. he earned his b.s. in business administration from bryant university and his ma and phd degrees from brown university. read more innovation pipeline colorectal cancer pancreatic cancer lung cancer press releases 2018-08-13 volitionrx limited announces second quarter 2018 financial results and business update 2018-08-13 preliminary data from study demonstrates 94% accuracy in detecting aggressive prostate cancer social responsibility we plan on funding research in schools and universities in modern biology to understand genetics, disease and inheritance. downloads team conditions social responsibility privacy policy disclaimer sign up to email

URL analysis for volitionrx.com

https://volitionrx.com/nu-q
https://volitionrx.com/#video-modal
https://volitionrx.com/news/press-releases
https://volitionrx.com/team
https://volitionrx.com/team/scott-powell
https://volitionrx.com/social-responsibility
https://volitionrx.com/team/jason-terrell
https://volitionrx.com/disclaimer
https://volitionrx.com/news/press-releases/preliminary-data-from-study-demonstrates-94-accuracy-in-detecting-aggressive-prostate-cancer
https://volitionrx.com/contact
https://volitionrx.com/team/jasmine
https://volitionrx.com/team/rod-rootsaert
https://volitionrx.com/news/press-releases/volitionrx-limited-announces-second-quarter-2018-financial-results-and-business-update
https://volitionrx.com/downloads
https://volitionrx.com/team/mark-eccleston

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: VOLITIONRX.COM
Registry Domain ID: 1597344399_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.1and1.com
Registrar URL: http://registrar.1and1.info
Updated Date: 2017-05-15T07:37:02Z
Creation Date: 2010-05-14T20:14:49Z
Registry Expiry Date: 2018-05-14T20:14:49Z
Registrar: 1&1 Internet SE
Registrar IANA ID: 83
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +1.6105601459
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS67.1AND1.CO.UK
Name Server: NS68.1AND1.CO.UK
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-10-08T01:11:24Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR 1&1 Internet SE

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =volitionrx.com

  PORT 43

  TYPE domain

DOMAIN

  NAME volitionrx.com

  CHANGED 2017-05-15

  CREATED 2010-05-14

STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited

NSERVER

  NS67.1AND1.CO.UK 217.160.80.173

  NS68.1AND1.CO.UK 217.160.81.173

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .